Literature DB >> 24529009

Impact of hospital volume on perioperative outcomes and costs of radical cystectomy: analysis of the Maryland Health Services Cost Review Commission database.

Michael A Gorin1, Max Kates, Jeffrey K Mullins, Phillip M Pierorazio, Brian R Matlaga, Mark P Schoenberg, Trinity J Bivalacqua.   

Abstract

INTRODUCTION: The objective of this study was to evaluate the impact of hospital case volume on perioperative outcomes and costs of radical cystectomy (RC) after controlling for differences in patient case mix.
MATERIALS AND METHODS: The Maryland Health Services Cost Review Commission database was queried for patients who underwent an open RC between 2000 and 2011. Patients were divided into tertiles based on hospital case volume. Groups were compared for differences in length of intensive care unit (ICU) stay, length of total hospital stay, rate of in-hospital deaths and procedure-related costs.
RESULTS: In total, 1620 patients underwent a RC during the study period. Of these patients, 457 (28.2%) underwent surgery at 37 low volume centers, 465 (28.7%) at six mid volume centers and 698 (43.1%) at a single high volume center. The mean case volume of each group was 1.1, 7.0 and 63.5 RC/center/year, respectively. After controlling for marked differences in patient case mix, having surgery at the single high-volume center was independently associated with a decrease in length of ICU stay (coefficient = -0.41 days, 95% CI -0.78--0.05, p = 0.03), in-hospital mortality (OR 0.18, 95% CI 0.04-0.80, p = 0.02) and total medical costs (coefficient = -2.91k USD, 95% CI -4.15--1.67, p < 0.001). Decreased total costs were driven by reductions in charges associated with the operating room, drugs, radiology tests, labs, supplies and physical/occupational therapy (all p < 0.001).
CONCLUSIONS: Undergoing RC at a high volume medical center was associated with improved outcomes and reduced costs. These data support the centralization of RC to high volume centers.

Entities:  

Mesh:

Year:  2014        PMID: 24529009

Source DB:  PubMed          Journal:  Can J Urol        ISSN: 1195-9479            Impact factor:   1.344


  7 in total

1.  Charlson comorbidity score is associated with readmission to the index operative hospital after radical cystectomy and correlates with 90-day mortality risk.

Authors:  Coleman McFerrin; Syed Johar Raza; Allison May; Facundo Davaro; Sameer Siddiqui; Zachary Hamilton
Journal:  Int Urol Nephrol       Date:  2019-07-25       Impact factor: 2.370

2.  Surgical landscape of radical cystectomy for bladder cancer in France over the last 10 years.

Authors:  Priscilla Léon; Thomas Seisen; Morgan Rouprêt
Journal:  World J Urol       Date:  2014-06-28       Impact factor: 4.226

3.  The impact of hospital volume on clinical and economic outcomes in ventral hernia repair: an analysis with national policy implications.

Authors:  A Chattha; J Muste; A Patel
Journal:  Hernia       Date:  2018-08-09       Impact factor: 4.739

4.  Cost comparison between open radical cystectomy, laparoscopic radical cystectomy, and robot-assisted radical cystectomy for patients with bladder cancer: a systematic review of segmental costs.

Authors:  Yasuhiro Morii; Takahiro Osawa; Teppei Suzuki; Nobuo Shinohara; Toru Harabayashi; Tomoki Ishikawa; Takumi Tanikawa; Hiroko Yamashina; Katsuhiko Ogasawara
Journal:  BMC Urol       Date:  2019-11-08       Impact factor: 2.264

5.  'Trifecta' outcomes of robot-assisted partial nephrectomy: Results of the 'low volume' surgeon.

Authors:  Cem Basatac; Haluk Akpinar
Journal:  Int Braz J Urol       Date:  2020 Nov-Dec       Impact factor: 1.541

6.  The Relationship between Centralization of Care and Geographic Barriers to Cystectomy for Bladder Cancer.

Authors:  Martin F Casey; Juan Wisnivesky; Valerie H Le; Umut Sarpel; Kristian D Stensland; William K Oh; Matthew D Galsky
Journal:  Bladder Cancer       Date:  2016-07-27

7.  Association between surgical volumes and real-world healthcare cost when using a mesh capturing device for pelvic organ prolapse: A 5-years comparison between single- versus multicenter use.

Authors:  Edward Morcos; Christian Falconer; Emilie Toresson Grip; Kirk Geale; Katarina Hellgren; Georgios Poutakidis; Daniel Altman
Journal:  Int Urogynecol J       Date:  2021-02-26       Impact factor: 2.894

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.